#115 - Sleep Deprivation for Depression

Induced wakefulness therapy, or sleep deprivation, serves as a rapid, non-pharmacological intervention for major depression, historically showing temporary remission in 40 to 60 percent of patients. This counterintuitive approach functions by throttling down hyperactive brain regions, such as the ventral anterior cingulate and amygdala, while modulating dopamine and serotonin systems. Despite these initial clinical successes, the therapeutic effect remains notoriously unstable, with relapse occurring rapidly upon sleep recovery. Recent rigorous meta-analyses challenge the efficacy of sleep deprivation when isolated from other chronotherapy components like bright light or medication. While clinicians continue to explore its use in psychiatric settings, the potential for side effects—including manic switches in bipolar patients—and the lack of consistent, long-term evidence necessitate a cautious, evidence-based approach to this paradoxical treatment.